Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-13

Clinical Trial Update: Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease [NA]

View source ↗

Summary

This clinical trial update discusses clock- and narcolepsy-related genetic variants and their potential relevance to sleep disorders in Parkinson's disease. It …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Asan Medical Center | Conditions: Parkinson Disease, Sleep Disorders | NA | Status: UNKNOWN